X-Linked Combined Immunodeficiency Diseases
Showing 1 - 25 of >10,000
Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)
Recruiting
- Severe Combined Immunodeficiency Disease, X-linked
- CL20-i4-EF1α-hγc-OPT
- +2 more
-
San Francisco, California
- +2 more
Jan 9, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)
Recruiting
- Severe Combined Immunodeficiency, X-Linked
- Lentiviral vector transduced CD34+ cells
-
London, Greater London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Mar 15, 2022
X-linked Severe Combined Immunodeficiency Trial in Paris (Gene transfer)
Completed
- X-linked Severe Combined Immunodeficiency
- Gene transfer
-
Paris, FranceHopital Necker
Sep 22, 2021
Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell
Recruiting
- Severe Combined Immunodeficiency, X Linked
- Gene Therapy
- autologous CD34+ cell transduced with G2SCID vector
-
Los Angeles, California
- +4 more
Jul 19, 2022
Gene Therapy Trial in Chongqing (Lentiviral Vector Gene Therapy)
Recruiting
- Gene Therapy
- Lentiviral Vector Gene Therapy
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Mar 26, 2020
Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,
Recruiting
- Bone Marrow Failure Syndrome
- +15 more
- Thiotepa--single daily dose
- Thiotepa--escalated dose
-
Gainesville, FloridaUF Health Shands Children's Hospital
Jul 8, 2021
Evaluation of Patients With Immune Function Abnormalities
Recruiting
- Chronic Granulomatous Disease (CGD)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
X-Linked Combined Immunodeficiency Diseases Trial run by the NIAID (CD34+ HSCs transduced with the lentivirus vector, VSV-G
Unknown status
- X-Linked Combined Immunodeficiency Diseases
- CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1α-hγc-OPT
- +2 more
-
Bethesda, MarylandLaboratory of Host Defenses (LHD), National Institute of Allergy
Dec 3, 2019
X-Linked Dystonia Parkinsonism Trial in Manila (transcranial magnetic resonance-guided focused ultrasound pallidothalamic
Available
- X-Linked Dystonia Parkinsonism
- transcranial magnetic resonance-guided focused ultrasound pallidothalamic tractotomy
-
Manila, PhilippinesPhilippine General Hospital
Aug 21, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
X-linked Hypophosphatemia, Hypophosphatemic Rickets, Hypophosphatemic Rickets, X-Linked Dominant Trial in Boston (Calcitriol)
Recruiting
- X-linked Hypophosphatemia
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 16, 2022
SCID, X Linked Trial in Beijing, Shenzhen (TYF-IL-2Rg gene-modified autologous stem cells)
Unknown status
- SCID, X Linked
- TYF-IL-2Rg gene-modified autologous stem cells
-
Beijing, Beijing, China
- +2 more
Sep 18, 2019
Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked Trial in Sacramento (Placebo Medication,
Active, not recruiting
- Fragile X Syndrome
- +9 more
- Placebo Medication
- Metformin
-
Sacramento, CaliforniaUC Davis MIND Institute
Feb 22, 2022
X-Linked Myotubular Myopathy (XLMTM) Subjects
Completed
- X-linked Myotubular Myopathy
-
Los Angeles, California
- +7 more
Jul 27, 2022
Exosome for Early Diagnosis of Bipolar Affective Disorder
Not yet recruiting
- Bipolar Affective Disorder
- Major Depressive Disorder
-
Tianjin, ChinaTianjin Anding Hospital
Jun 13, 2023
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Development of Non-Invasive Prenatal Diagnosis for Single Gene
Not yet recruiting
- Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including
- +14 more
- Blood sample
-
Paris, FranceHôpital Cochin, Maternité Port-Royal, service de Gynécologie obs
Nov 24, 2023
Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)
Recruiting
- Multiple Myeloma
- anti-BCMA CAR-T
- Selinexor-VRD
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023
Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked Trial in Edmonton, Montreal (Placebo
Recruiting
- Fragile X Syndrome
- +9 more
- Placebo Medication
- Metformin
-
Edmonton, Alberta, Canada
- +1 more
Sep 16, 2021
Study of Smith-Lemli-Opitz Syndrome
Completed
- Smith-Lemli-Opitz Syndrome
- Cholesterol Suspension
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Human Immunodeficiency Virus I Infection Trial in Lyon (Blood collection.)
Not yet recruiting
- Human Immunodeficiency Virus I Infection
- Blood collection.
-
Lyon, FranceService des maladies infectieuses et tropicales Hôpital de la Cr
Jan 21, 2022
Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic Trial in Little Rock, Sacramento, Atlanta
Recruiting
- Muscular Dystrophies
- +7 more
- CAP-1002
- Placebo
-
Little Rock, Arkansas
- +9 more
Jan 9, 2023